We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
FLAM
1726
First Light Asset Management
Minnesota
$340K
ERIM
1727
Eagle Ridge Investment Management
Connecticut
$338K +$27.7K +880 +9%
TSS
1728
Two Sigma Securities
New York
$338K +$347K +11,031 New
ARM
1729
Adirondack Research & Management
New York
$337K
FCT
1730
Family Capital Trust
Massachusetts
$336K
HBT
1731
Hills Bank & Trust
Iowa
$335K -$15K -477 -4%
LFG
1732
LifePlan Financial Group
Ohio
$335K
HHAA
1733
Henry H. Armstrong Associates
Pennsylvania
$332K +$26.5K +843 +8%
SRP
1734
Saddle Road Partners
Nebraska
$332K +$341K +10,848 New
ACM
1735
Advisors Capital Management
New Jersey
$331K +$340K +10,821 New
ZAM
1736
Zevin Asset Management
Massachusetts
$328K
KWMG
1737
King Wealth Management Group
Florida
$326K -$12K -383 -3%
NYLT
1738
New York Life Trust
New York
$326K -$2.23K -71 -0.7%
CWP
1739
Capital Wealth Planning
Florida
$323K -$484K -15,378 -59%
TL
1740
Tirschwell & Loewy
New York
$323K +$101K +3,215 +44%
HIM
1741
Harbour Investment Management
Washington
$322K
HCM
1742
Harvey Capital Management
Florida
$322K
HCIA
1743
Hochman Cole Investment Advisors
Illinois
$322K +$331K +10,519 New
PCM
1744
Pointe Capital Management
Michigan
$321K -$39.4K -1,252 -11%
MCM
1745
Marathon Capital Management
Maryland
$320K -$216K -6,851 -40%
AMG
1746
Advisors Management Group
Wisconsin
$320K +$328K +10,438 New
MWM
1747
Modera Wealth Management
New Jersey
$318K -$14.1K -448 -4%
MI
1748
Montage Investments
Kansas
$316K +$324K +10,314 New
HCM
1749
Highbridge Capital Management
New York
$314K -$16.8M -533,961 -98%
PIM
1750
Parasol Investment Management
Illinois
$314K -$36.3K -1,155 -10%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.